Tag: Cardiovascular Systems
Vascular News’ top 10 most popular stories of February 2023
February's top 10 includes the announcement that Abbott is to acquire Cardiovascular Systems, results of the PRESERVE study on the safety and effectiveness of...
Vascular News’ top 10 most popular stories of January 2023
January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...
Cardiovascular Systems enrols first patient in Japan for KAIZEN clinical study
Cardiovascular Systems Inc (CSI) recently announced initiation of the KAIZEN clinical study of its Diamondback 360 peripheral orbital atherectomy system (OAS) for the treatment...
Cardiovascular Systems announces US FDA 510(k) submission of Innova Vascular’s thrombectomy...
Cardiovascular Systems (CSI) announced that Innova Vascular (Innova) has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its...
Cardiovascular Systems announces full market release of the 2.00 Max Crown...
Cardiovascular Systems Inc (CSI) has announced the full market release of the 2.00 Max Crown for peripheral orbital atherectomy systems (2.00 Max Crown).
CSI notes...
Cardiovascular Systems announces first in-human experience with peripheral everolimus DCB
Cardiovascular Systems Inc (CSI) has announced the start of enrolment in a first in-human trial of the peripheral everolimus drug-coated balloon (DCB) being developed...
Vascular News’ top 10 most popular stories of February 2022
February's top 10 includes a consensus statement from the Society for Vascular Surgery (SVS) and the Enhanced Recovery after Surgery (ERAS) Society on perioperative...
Cardiovascular Systems partners with Innova Vascular to develop full line of...
Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.
According to a...
Cardiovascular Systems announces development of IVL technology for the treatment of...
Cardiovascular Systems recently announced that it has made significant progress towards the commercialisation of intravascular lithotripsy (IVL) systems for the treatment of calcific coronary...
First patient treated with Cardiovascular Systems’ ViperCross peripheral support catheter
Cardiovascular Systems recently announced that the first patient has been successfully treated with its ViperCross peripheral support catheter.
Billy J Kim (The Surgical Clinic, Nashville,...
Cardiovascular Systems announces US commercial launch of Jade OTW non-compliant peripheral...
Cardiovascular Systems has announced that the full line of OrbusNeich Jade percutaneous transluminal angioplasty (PTA) over-the-wire (OTW) balloon catheters is now available in the...
Cardiovascular Systems announces acquisition of peripheral support catheters From WavePoint Medical
Cardiovascular Systems recently announced that it has acquired a line of peripheral support catheters from WavePoint Medical.
Peripheral support catheters are used during peripheral vascular...
Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus...
Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs).
Under the terms of the...
Cardiovascular Systems introduces peripheral orbital atherectomy system with GlideAssist in Europe
Cardiovascular Systems announced today that the first patient in Europe has been treated with its Stealth 360 peripheral orbital atherectomy system (OAS) 1.25mm Micro...
Cardiovascular Systems announces first patient enrolled in REACH PVI clinical study
Cardiovascular Systems recently announced that the first patient has been enrolled in the REACH PVI study. The purpose of this study is to prospectively...
Cardiovascular Systems announces first patient enrolled in REACH PVI clinical study
Cardiovascular Systems recently announced that the first patient has been enrolled in the REACH PVI study. The purpose of this study is to prospectively...
First patients treated in United States with OrbusNeich Teleport Microcatheter
The first patients in the United States have been treated using the OrbusNeich Teleport Microcatheter (Teleport; Cardiovascular Systems), which recently received US Food and...
First European patients treated with Peripheral Orbital atherectomy system
The first patients in Germany have been treated with the Stealth 360 Peripheral Orbital Atherectomy System (OAS; Cardiovascular Systems Inc). The German cases represent...
Cardiovascular Systems signs international distribution agreement with OrbusNeich
Cardiovascular Systems, Inc. (CSI) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral orbital atherectomy systems (OAS) outside...
First patients treated with new peripheral orbital atherectomy device
Cardiovascular Systems, a medical device company developing and commercialising interventional treatment systems for peripheral and coronary artery disease, announced today that the first patients were...
Cardiovascular Systems announces partnerships with OrbusNeich and Integer
Cardiovascular Systems (CSI) has announced two new partnerships broadening the company’s product portfolio. According to a company release, CSI is now the exclusive US...
Lesion preparation using Diamondback 360 orbital atherectomy enhances paclitaxel distribution in...
CBSET, a not-for-profit preclinical research institute dedicated to translational research, education, and advancement of medical technologies, has announced that its scientists have published data...
Lasting benefits following endovascular intervention in critical limb ischaemia
One-year data from Cardiovascular System’s all-comers LIBERTY 360 clinical study have demonstrated sustained benefits following endovascular intervention in critical limb ischaemia patients.
The data were...
LIBERTY 360 degrees sub-analysis shows high freedom from adverse events with...
A new sub-analysis from Cardiovascular System’s LIBERTY 360 study supports the use of the company’s Diamondback 360 peripheral orbital atherectomy system (OAS) during endovascular...
Study demonstrates sustained benefit of endovascular intervention in patients with lower...
Cardiovascular systems (CSI) presented six-month data from its LIBERTY 360 degrees post-market study in a presentation at the 29th International Symposium on Endovascular Therapy...
